| |
| |
|
| Insider
Information: |
Fisher Stewart |
| Relationship: |
Chief Scientific Officer |
| City: |
Watertown |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
129,121 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
129,121 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
C4 Therapeutics, Inc. |
CCCC |
Chief Scientific Officer |
2024-02-14 |
129,121 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CCCC |
C4 Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2024-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
27,300 |
129,121 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2024-02-13 |
4 |
D |
$6.53 |
$14,725 |
D/D |
(2,255) |
101,821 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2023-08-30 |
4 |
D |
$2.93 |
$1,937 |
D/D |
(661) |
104,076 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2023-08-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,250 |
104,737 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2023-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
26,000 |
102,487 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2023-01-30 |
4 |
D |
$7.78 |
$10,122 |
D/D |
(1,301) |
76,487 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2023-01-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,750 |
77,788 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2022-05-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,750 |
75,140 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2022-04-12 |
4 |
OE |
$3.71 |
$137,120 |
D/D |
28,084 |
71,390 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-12-08 |
4 |
OE |
$2.11 |
$73,000 |
D/D |
20,562 |
43,306 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-08-03 |
4 |
AS |
$45.01 |
$767,812 |
D/D |
(17,057) |
22,744 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-08-02 |
4 |
AS |
$45.00 |
$814,756 |
D/D |
(18,104) |
39,801 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-07-29 |
4 |
AS |
$45.00 |
$2,259,631 |
D/D |
(50,211) |
57,905 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2021-02-03 |
4 |
OE |
$2.11 |
$26,999 |
D/D |
8,300 |
108,116 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Chief Scientific Officer |
• – – |
2020-12-11 |
4 |
OE |
$2.11 |
$45,998 |
D/D |
14,444 |
99,816 |
0 |
- |
|
| CCCC |
C4 Therapeutics, Inc. |
Chief Scientific OfficerOffice |
• – – |
2020-10-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
85,372 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
